📺 Watch the First Cell & Gene Therapy Helix Event Hosted by Crowdhelix, the first Cell & Gene Therapy Helix Event saw leading European innovators describe the multidisciplinary approaches they are employing to develop next generation CGT manufacturing tools. Aimed at academic researchers, R&D organisations, regulatory professionals, industry representatives, and manufacturing organisations, the Helix event heard from four expert speakers. The event concluded with an engaging Q&A session, where does in attendance got the opportunity to share their thoughts and ask questions of the speakers. Speakers at the First CGT Helix Event 🎤 Mariana Werner Sunderland - Senior Scientist II, Achilles Therapeutics plc, and SMARTERproject 🎤 Daniela Buchmayr - CEO & Co-Founder, Sarcura GmbH 🎤 Dorothea Ledergerber - Independent Expert 🎤 Thomas Eaton - COO and Co-Founder, Limula, PAT4CGT Project
PAT4CGT Project’s Post
More Relevant Posts
-
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
-
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
-
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
-
Knowing the critical process parameters of a cell culture process that can influence the quality attributes is the basis of efficient #bioprocessing. This knowledge has an even greater importance on the novel field of #NKcell therapies, where the number of cells and their growth is limited. Our review article summarizes the current, experimental knowledge on #NKcell manufacturing, based on a statistical analysis of available literature, creating the knowledge foundation of #NKcell process development. https://lnkd.in/d5fwFszM Yes, IBD group is actively researching on the field of #celltherapies! Stay tuned for more!
-
-
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
-
“Automation and data management are making room for innovations, bringing lifesaving therapies to people at a rapid rate without compromising on quality or accuracy,” said Carola Schmidt, general manager of automated robotic systems at Revvity. Read this Genetic Engineering & Biotechnology News article to learn more about how automation benefits labs in an ecosystem and what specific solutions Revvity is bringing to it: http://ms.spr.ly/6042iSwxE
Laboratory Automation Leverages Artificial Intelligence
genengnews.com
-
Biosciences Account Manager - Thermo Fisher Scientific | Providing life science professionals with the tools to pursue excellence and innovation
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
-
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
-
Catch the webinar replay to hear Fabio Fachin from Takeda and Mina Ahmadi, Ph.D. from Thermo Fisher Scientific discuss how new technologies can help shorten the CAR T cell therapy manufacturing process and reduce failure rates. Watch it now!
On-demand webinar: Automated 24‑hour CAR T manufacturing process
thermofisher.com
